EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pressure BioSciences's enterprise value is $27.40 Mil.
Pressure BioSciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $2.27 Mil. Therefore, Pressure BioSciences's EV-to-Revenue for today is 12.05.
The historical rank and industry rank for Pressure BioSciences's EV-to-Revenue or its related term are showing as below:
PBIO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.97 Med: 7.25 Max: 27.89
Current: 12.05
During the past 13 years, the highest EV-to-Revenue of Pressure BioSciences was 27.89. The lowest was 1.97. And the median was 7.25.
PBIO's EV-to-Revenue is ranked worse than 84.26% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.245
vs PBIO: 12.05
Pressure BioSciences EV-to-Revenue Historical Data
The historical data trend for Pressure BioSciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pressure BioSciences's EV-to-Revenue
For the Medical Devices subindustry, Pressure BioSciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pressure BioSciences's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Pressure BioSciences's EV-to-Revenue falls into.
Pressure BioSciences's current Enterprise Value is $27.40 Mil.
Pressure BioSciences's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pressure BioSciences's share price for today is $0.22.
Pressure BioSciences's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pressure BioSciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences (Pressure BioSciences) Business Description
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 